Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on June 19, 2003; DOI 10.1182/blood-2003-01-0213.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-01-0213v1
102/7/2491    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butta, N.
Right arrow Articles by Parrilla, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butta, N.
Right arrow Articles by Parrilla, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted January 24, 2003
Accepted June 6, 2003

Disruption of the {beta}3 663-687 disulfide bridge confers constitutive activity to {beta}3 integrins

Nora Butta, Elena G Arias-Salgado, Consuelo Gonzalez-Manchon, Milagros Ferrer, Susana Larrucea, Matilde S Ayuso, and Roberto Parrilla*

Pathophysiology and Human Molecular Genetics, Centro Invest. Biol. (CSIC), Madrid, Madrid, Spain

* Corresponding author; email: rparrilla{at}cib.csic.es.

The platelet fibrinogen receptor, integrin {alpha}IIb{beta}3, is a non-covalent heterodimer of glycoproteins GPIIb and GPIIIa. This work aimed at elucidating the role played by the carboxyterminal extracellular, transmembrane, and cytoplasmic regions of the glycoprotein {beta}3 in the formation of functional complexes with {alpha} subunits. Progressive carboxyterminal deletions of {beta}3 revealed that surface exposure of {alpha}IIb{beta}3 or {alpha}v{beta}3 could not take place in the absence of the transmembrane domain of {beta}3. In contrast, internal deletions (616 to 690) of the carboxyterminal regions of the {beta}3 ectodomain led to surface exposure of constitutive active receptors in CHO cells, as indicated by the enhanced rate of cell adhesion to immobilized ligands and spontaneous binding to soluble fibrinogen or activation-dependent antibody PAC-1. The functional analysis of cysteine mutations within the 616-690 region of {beta}3 or chimeric {beta}3-{beta}7 subunits revealed that disruption of the C663-C687 disulfide bridge endows constitutive activity to the aIIbb3 receptor. It is concluded that the carboxyterminal tail of the {beta}3 ectodomain, so called {beta}TD domain, is not essential for cell surface expression of {beta}3 receptors. However, a basal, non-activated, low ligand affinity state of the {beta}3 integrins demands a normal conformation of this domain.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
P. Gresele, E. Falcinelli, S. Giannini, P. D'Adamo, A. D'Eustacchio, T. Corazzi, A. M. Mezzasoma, F. Di Bari, G. Guglielmini, L. Cecchetti, et al.
Dominant inheritance of a novel integrin {beta}3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families
Haematologica, May 1, 2009; 94(5): 663 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Mor-Cohen, N. Rosenberg, M. Landau, J. Lahav, and U. Seligsohn
Specific Cysteines in {beta}3 Are Involved in Disulfide Bond Exchange-dependent and -independent Activation of {alpha}IIb{beta}3
J. Biol. Chem., July 11, 2008; 283(28): 19235 - 19244.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Chaurasia, J. A. Aguirre-Ghiso, O. D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski
A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with {alpha}5beta1 Integrin and Tumor Growth
J. Biol. Chem., May 26, 2006; 281(21): 14852 - 14863.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kamata, M. Handa, Y. Sato, Y. Ikeda, and S. Aiso
Membrane-proximal {alpha}/{beta} Stalk Interactions Differentially Regulate Integrin Activation
J. Biol. Chem., July 1, 2005; 280(26): 24775 - 24783.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
B. D. Adair, J.-P. Xiong, C. Maddock, S. L. Goodman, M. A. Arnaout, and M. Yeager
Three-dimensional EM structure of the ectodomain of integrin {alpha}V{beta}3 in a complex with fibronectin
J. Cell Biol., March 28, 2005; 168(7): 1109 - 1118.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. J. Calvete
Structures of Integrin Domains and Concerted Conformational Changes in the Bidirectional Signaling Mechanism of {alpha}IIb{beta}3
Experimental Biology and Medicine, September 1, 2004; 229(8): 732 - 744.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Chigaev, G. J. Zwartz, T. Buranda, B. S. Edwards, E. R. Prossnitz, and L. A. Sklar
Conformational Regulation of {alpha}4{beta}1-Integrin Affinity by Reducing Agents: "INSIDE-OUT" SIGNALING IS INDEPENDENT OF AND ADDITIVE TO REDUCTION-REGULATED INTEGRIN ACTIVATION
J. Biol. Chem., July 30, 2004; 279(31): 32435 - 32443.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020